Covered recipient · General Payments record
JENNIFER LEE
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2019–2024
$2,043.98
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $936.38 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $359.82 | 13 |
| GENZYME CORPORATION | $127.00 | 1 |
| Incyte Corporation | $106.48 | 4 |
| E.R. Squibb & Sons, L.L.C. | $77.35 | 3 |
| PFIZER INC. | $75.87 | 3 |
| Lilly USA, LLC | $72.23 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $37.36 | 2 |
| LEO Pharma Inc. | $25.00 | 1 |
| Janssen Biotech, Inc. | $24.42 | 1 |
| Arcutis Biotherapeutics, Inc. | $17.65 | 1 |
| UCB, Inc. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.20 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153212 | CMS |
| ABBVIE INC. | $32.87 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153214 | CMS |
| ABBVIE INC. | $33.97 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153216 | CMS |
| ABBVIE INC. | $31.85 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153218 | CMS |
| ABBVIE INC. | $32.94 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153220 | CMS |
| ABBVIE INC. | $29.96 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153222 | CMS |
| ABBVIE INC. | $24.89 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153224 | CMS |
| ABBVIE INC. | $33.17 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153226 | CMS |
| ABBVIE INC. | $26.79 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153228 | CMS |
| ABBVIE INC. | $8.07 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153230 | CMS |
| ABBVIE INC. | $18.40 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153232 | CMS |
| ABBVIE INC. | $33.56 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153234 | CMS |
| ABBVIE INC. | $21.15 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104153236 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.65 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121053229 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101521529 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.79 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101521561 | CMS |
| E.R. Squibb & Sons, L.L.C. | $32.00 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101521664 | CMS |
| GENZYME CORPORATION | $127.00 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140010910 | CMS |
| Incyte Corporation | $27.74 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141218436 | CMS |
| Incyte Corporation | $24.97 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141294862 | CMS |
| Incyte Corporation | $24.96 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141297122 | CMS |
| Incyte Corporation | $28.81 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141217560 | CMS |
| Janssen Biotech, Inc. | $24.42 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078698300 | CMS |
| LEO Pharma Inc. | $25.00 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152639721 | CMS |
| Lilly USA, LLC | $27.22 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135016578 | CMS |
| Lilly USA, LLC | $21.38 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135044130 | CMS |
| Lilly USA, LLC | $23.63 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135063353 | CMS |
| PFIZER INC. | $20.46 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131143844 | CMS |
| PFIZER INC. | $25.85 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131504061 | CMS |
| PFIZER INC. | $29.56 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131152290 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.32 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152159272 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $22.04 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152159270 | CMS |
| UCB, Inc. | $13.20 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143074818 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.